| 产品详情 |
| Edit |   |
| Product Name | SUMO1, Recombinant, Human |
| Description | Purity ~90% (SDS-PAGE). SUMO modification has been implicated in functions such as nuclear transport, chromosome segregation and transcriptional regulation. SUMO1 functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. Still, unlike ubiquitin which targets proteins for degradation, SUMO1 is involved in a variety of cellular processes, for example nuclear transport, transcriptional regulation, apoptosis, and protein stability. SUMO1 is not active until the last four amino acids of the carboxy-terminus are cleaved off. The active recombinant SUMO-1 protein is derived from the precursor pro-SUMO-1 (Accession # NM_003352). Human SUMO-1 shares 46% and 47% identity with SUMO-2 and SUMO-3 respectively. SUMOylation can occur without the requirement of a specific E3 ligase activity, where SUMO is transferred directly from UbcH9 to specific substrates. SUMOylated substrates are primarily localized to the nucleus (RanG |
| Size | 100ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | SUMO1, Recombinant, Human (Small Ubiquitin-related Modifier 1, SUMO-1, Sentrin, Ubiquitin-like Protein SMT3C, SMT3 Homolog 3, Ubiquitin-homology Domain Protein PIC1, Ubiquitin-like Protein UBL1, GAP-modifying Protein 1, GMP1, SUMO1, SMT3C, SMT3H3, UBL1, PIC1, SMT3, DAP-1, OFC10, SENP2) |
| Gene, Accession, CAS # | SUMO1, Gene ID: 7341, SwissProt: P63165 |
| Catalog # | 220290 |
| Price | |
| Order / More Info | SUMO1, Recombinant, Human from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|